Howard Hughes Medical Institute
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Howard Hughes Medical Institute reported 2 stock positions worth $568.4 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 99.9% of the portfolio, followed by Bioage Labs (BIOA, 0.1%). Compared with Q3 2024, it reduced 1. The biggest sale was SS SPDR S&P 500 ETF Trust-US (SPY, shares −12%).
- Most Recent 13F
- Q2 2026
- Location
- Chevy Chase, MD
- CIK
- 0000810386
- Portfolio Value
- $568.4M (Q4 2024)
- SEC Filing
- 0000950123-25-002281 ↗ filed Feb 14, 2025
Holdings Value
Holdings 2 stocks · $568.4M
Portfolio Sells Q3 2024 → Q4 2024
| SPY SS SPDR S&P 500 ETF Trust-US | Reduce -11.5% | 99.88% | +0.26 |
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 30 | $445.4M | NVDA, AAPL, GOOGL, MSFT, TSM |
| Q1 2026 | 31 | $415.8M | SPY, NVDA, AAPL, GOOGL, MSFT |
| Q4 2025 | 500 | $174.7M | SPY, NVDA, AAPL, MSFT, AMZN |
| Q3 2025 | 500 | $170.6M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q2 2025 | 501 | $250.9M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q1 2025 | 2 | $202.2M | SPY, BIOA |
| Q4 2024 | 2 | $568.4M | SPY, BIOA |
| Q3 2024 | 2 | $630.4M | SPY, BIOA |
| Q2 2024 | 1 | $466.2M | SPY |
| Q1 2024 | 2 | $332.9M | SPY, PCT |